BXP vs. ANCR, AGY, APH, CEL, EAH, VLG, BMK, AVCT, OXB, and HVO
Should you be buying Beximco Pharmaceuticals stock or one of its competitors? The main competitors of Beximco Pharmaceuticals include Animalcare Group (ANCR), Allergy Therapeutics (AGY), Alliance Pharma (APH), Celadon Pharmaceuticals (CEL), ECO Animal Health Group (EAH), Venture Life Group (VLG), Benchmark (BMK), Avacta Group (AVCT), Oxford Biomedica (OXB), and hVIVO (HVO). These companies are all part of the "medical" sector.
Animalcare Group (LON:ANCR) and Beximco Pharmaceuticals (LON:BXP) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, earnings, risk, media sentiment, institutional ownership, profitability, community ranking, analyst recommendations and valuation.
In the previous week, Animalcare Group had 1 more articles in the media than Beximco Pharmaceuticals. MarketBeat recorded 1 mentions for Animalcare Group and 0 mentions for Beximco Pharmaceuticals. Beximco Pharmaceuticals' average media sentiment score of 0.41 beat Animalcare Group's score of 0.00 indicating that Animalcare Group is being referred to more favorably in the media.
Animalcare Group received 46 more outperform votes than Beximco Pharmaceuticals when rated by MarketBeat users. Likewise, 69.37% of users gave Animalcare Group an outperform vote while only 64.67% of users gave Beximco Pharmaceuticals an outperform vote.
Beximco Pharmaceuticals has higher revenue and earnings than Animalcare Group. Beximco Pharmaceuticals is trading at a lower price-to-earnings ratio than Animalcare Group, indicating that it is currently the more affordable of the two stocks.
Beximco Pharmaceuticals has a net margin of 11.80% compared to Beximco Pharmaceuticals' net margin of 1.61%. Animalcare Group's return on equity of 10.29% beat Beximco Pharmaceuticals' return on equity.
Animalcare Group has a beta of 0.5, indicating that its stock price is 50% less volatile than the S&P 500. Comparatively, Beximco Pharmaceuticals has a beta of 0.64, indicating that its stock price is 36% less volatile than the S&P 500.
44.7% of Animalcare Group shares are held by institutional investors. Comparatively, 1.6% of Beximco Pharmaceuticals shares are held by institutional investors. 29.7% of Animalcare Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Animalcare Group pays an annual dividend of GBX 5 per share and has a dividend yield of 2.3%. Beximco Pharmaceuticals pays an annual dividend of GBX 3 per share and has a dividend yield of 8.2%. Animalcare Group pays out 25,000.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Beximco Pharmaceuticals pays out 3,750.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Beximco Pharmaceuticals is clearly the better dividend stock, given its higher yield and lower payout ratio.
Summary
Beximco Pharmaceuticals beats Animalcare Group on 9 of the 17 factors compared between the two stocks.
Get Beximco Pharmaceuticals News Delivered to You Automatically
Sign up to receive the latest news and ratings for BXP and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding BXP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Beximco Pharmaceuticals Competitors List
Related Companies and Tools
